Elixir Medical Announces Significant Late Breaking Clinical Results for DynamX(R) Bioadaptor Demonstrating Nearly 50% Reduction in Coronary Event Rates vs. Current PCI Standard of Care
Elixir Medical Announces Significant Late Breaking Clinical Results for DynamX(R) Bioadaptor Demonstrating Nearly 50% Reduction in Coronary Event Rates vs. Current PCI Standard of Care GlobeNewswire October 27, 2025 Results were presented at the Transcatheter Cardiovascular Therapeutics (TCT) Conference 2025 in San Francisco on October 27, 2025 DynamX(R) bioadaptor is the first interventional technology to […]